On 21 June 2021, the Chinese National Medical Products Administration (NMPA) published two draft standards to clarify some of the requirements set out in the new drug traceability codes. The guidelines include information on both machine and human readable formats, and the printing quality that is required to reach C (1.5) or above.
The drug traceability code is used to uniquely identify a packaged unit for sale at each level of packaging, consisting of a list of numbers, letters, and/or symbols.
The deadline for public comment and consultation on the draft standards is 20 July 2021.
Reach out to RegASK to know more about China regulations. Get in touch with RegASK’s experts.
Contact RegASK for more details Read more
